By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878




Company News
Synthetic Biologics, Inc. (SYN) Appoints Raymond Stapleton, PhD, As Senior Vice President, Manufacturing 10/1/2015 6:14:35 AM
Synthetic Biologics, Inc. (SYN) Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial 9/28/2015 6:00:31 AM
Synthetic Biologics, Inc. (SYN) Reports First Analysis Demonstrating SYN-004's Ability To Protect The Microbiome From Damage Caused By IV Antibiotics In A Humanized Pig Model 9/21/2015 12:56:25 PM
Intrexon Corporation And Synthetic Biologics, Inc. (SYN) Enter ECC To Develop Novel Biotherapeutics For Treatment Of Phenylketonuria 8/10/2015 6:34:30 AM
Synthetic Biologics, Inc. (SYN) To Report Second Quarter Results On August 10, 2015 7/29/2015 12:58:16 PM
Synthetic Biologics, Inc. (SYN) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 7/21/2015 9:12:57 AM
Synthetic Biologics, Inc. (SYN) Announces Pricing Of $40.0 Million Public Offering 7/16/2015 7:53:07 AM
Synthetic Biologics, Inc. (SYN) Announces Public Offering Of Common Stock 7/16/2015 6:55:15 AM
Synthetic Biologics, Inc. (SYN)' Initiates SYN-010 Phase 2 Clinical Trial To Treat Irritable Bowel Syndrome With Constipation (IBS-C) 6/29/2015 6:21:39 AM
First Participant Dosed In Synthetic Biologics, Inc. (SYN)' Second Phase 2a Clinical Trial To Protect The Microbiome And Prevent C. difficile 6/12/2015 6:17:28 AM